Aytu Biopharma (AYTU) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to -$30.0 million.
- Aytu Biopharma's Enterprise Value fell 4719.58% to -$30.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$30.0 million, marking a year-over-year decrease of 4719.58%. This contributed to the annual value of -$31.0 million for FY2025, which is 5471.36% down from last year.
- Aytu Biopharma's Enterprise Value amounted to -$30.0 million in Q4 2025, which was down 4719.58% from -$32.6 million recorded in Q3 2025.
- Aytu Biopharma's 5-year Enterprise Value high stood at -$18.2 million for Q1 2025, and its period low was -$50.2 million during Q2 2021.
- Its 5-year average for Enterprise Value is -$26.8 million, with a median of -$21.7 million in 2023.
- As far as peak fluctuations go, Aytu Biopharma's Enterprise Value surged by 6139.81% in 2022, and later crashed by 6227.37% in 2025.
- Over the past 5 years, Aytu Biopharma's Enterprise Value (Quarter) stood at -$35.3 million in 2021, then skyrocketed by 44.72% to -$19.5 million in 2022, then fell by 0.14% to -$19.5 million in 2023, then decreased by 4.45% to -$20.4 million in 2024, then plummeted by 47.2% to -$30.0 million in 2025.
- Its Enterprise Value was -$30.0 million in Q4 2025, compared to -$32.6 million in Q3 2025 and -$31.0 million in Q2 2025.